Literature DB >> 19896393

Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Cecille D Browne1, Christopher J Del Nagro, Matthew H Cato, Hart S Dengler, Robert C Rickert.   

Abstract

Anergy is a critical physiologic mechanism to sensor self-reactive B cells. However, a biochemical understanding of how anergy is achieved and maintained is lacking. Herein, we investigated the role of the phosphoinositide 3-kinase (PI3K) lipid product PI(3,4,5)P(3) in B cell anergy. We found reduced generation of PI(3,4,5)P(3) in anergic B cells, which was attributable to reduced phosphorylation of the PI3K membrane adaptor CD19, as well as increased expression of the inositol phosphatase PTEN. Sustained production of PI(3,4,5)P(3) in B cells, achieved through conditional deletion of Pten, resulted in failed tolerance induction and abundant autoantibody production. In contrast to wild-type immature B cells, B cell receptor engagement of PTEN-deficient immature B cells resulted in activation and proliferation, indicating a central defect in early B cell responsiveness. These findings establish repression of the PI3K signaling pathway as a necessary condition to avert the generation, activation, and persistence of self-reactive B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896393      PMCID: PMC2788083          DOI: 10.1016/j.immuni.2009.08.026

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.

Authors:  Dennis C Otero; Amy N Anzelon; Robert C Rickert
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

3.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

Authors:  Robin Lesley; Ying Xu; Susan L Kalled; Donna M Hess; Susan R Schwab; Hong-Bing Shu; Jason G Cyster
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

4.  Protein kinase Cdelta controls self-antigen-induced B-cell tolerance.

Authors:  Ingrid Mecklenbräuker; Kaoru Saijo; Nai-Ying Zheng; Michael Leitges; Alexander Tarakhovsky
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

5.  CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing.

Authors:  Eran Diamant; Zohar Keren; Doron Melamed
Journal:  Blood       Date:  2005-01-11       Impact factor: 22.113

6.  Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.

Authors:  Lixin Rui; Carola G Vinuesa; Julie Blasioli; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

7.  Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function.

Authors:  Amy N Anzelon; Hong Wu; Robert C Rickert
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

Review 8.  Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.

Authors:  Jesse E Jun; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2003-11       Impact factor: 25.606

9.  B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Authors:  Tri Giang Phan; Michelle Amesbury; Sandra Gardam; Jeffrey Crosbie; Jhagvaral Hasbold; Philip D Hodgkin; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

10.  Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination.

Authors:  Akira Suzuki; Tsuneyasu Kaisho; Minako Ohishi; Manae Tsukio-Yamaguchi; Takeshi Tsubata; Pandelakis A Koni; Takehiko Sasaki; Tak Wah Mak; Toru Nakano
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  56 in total

1.  TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.

Authors:  Zhangguo Chen; Alexandra Krinsky; Rachel A Woolaver; Xiaoguang Wang; Samantha M Y Chen; Vince Popolizio; Ping Xie; Jing H Wang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

3.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

Review 4.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 5.  MicroRNA control of B cell tolerance, autoimmunity and cancer.

Authors:  Changchun Xiao; David Nemazee; Alicia Gonzalez-Martin
Journal:  Semin Cancer Biol       Date:  2020-08       Impact factor: 15.707

Review 6.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

7.  A role for IRF8 in B cell anergy.

Authors:  Simanta Pathak; Shibin Ma; Vipul Shukla; Runqing Lu
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

8.  Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD.

Authors:  Alina E Dulau Florea; Raul C Braylan; Kristian T Schafernak; Kelli W Williams; Janine Daub; Rakesh K Goyal; Jennifer M Puck; V Koneti Rao; Stefania Pittaluga; Steven M Holland; Gulbu Uzel; Katherine R Calvo
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

Review 9.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

10.  Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways.

Authors:  John C Cambier
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.